Pfizer ends deal to placate Trump, announces plan to raise prices on 41 prescription drugs

...

The price halt -- and its quick end -- comes after Pfizer reaped major rewards from the Republican tax cut passed last year. As ThinkProgress' Rebekah Entralgo reported earlier this year, Pfizer predicted that the company would receive a tax cut of over $1 billion in 2018 alone and that it would pay a tax rate of just 17 percent. That is, as she noted, much lower than what many working families pay.